MCL1 and acute myeloid leukemia: Besides, CDK9 inactivation could reduce the expression of high turnover proteins like c-Myc and MCL-1, which are involved in regulating leukemia cell survival.422 Thus, CDK9 inactivation is considered valuable for AML therapy.